Who we are

Cure Mucolipidosis is a charity with one focus - to cure mucolipidosis!

We are a diverse group of people who have been impacted by mucolipidosis.

Cure Mucolipidosis is a not-for-profit organization established as a 501 c3 on 18th May 2021.

The organization is located in Illinois and has a mission to work alongside the Mucolipidosis Collaborative Research Network (MCRN) that was established in 2019 to help set a pipeline for the investigation of new modes of therapies for Mucolipidosis.

Our mission & vision

Cure Mucolipidosis is a global organization that is committed to the identification and treatment of Mucolipidosis through education, advocacy and research.

We form partnerships with Science, Medicine and industry and work towards finding a cure for people affected by Mucolipidosis globally

Our vision is to serve as a resource for stakeholders in the work, identification, treatment, and continual developments towards a cure for Mucolipidosis. We will help promote and support a global multi-stakeholder collaboration for Mucolipidosis.

We will also help to identify patient numbers globally in preparation for clinical trials and drug company development for a therapy or cure.

Our partners

Cure Mucolipidosis has a single Focus - to help find therapies for this group of rare Lysosomal Storage Diseases.

Cure Mucolipidosis supports the following disorders.

  • Mucolipidosis II alpha/beta

  • Mucolipidosis II/III alpha/beta

  • Mucolipidosis III alpha/beta

  • Mucolipidosis III Gamma

  • Sialidosis (Mucolipidosis I)

Meet the Team

  • Jackie James

    President

    Illinois, USA

  • Jenny Noble

    Vice President - Research/Admin

    New Zealand

  • Kevin Gates

    Treasurer

    USA

  • Truls Roll

    Head of European Operations

    Norway

  • Susan Kester

    Family Support

    USA

  • Nadia Jack

    Social Media/Communications

    New Zealand

  • Dan Peach

    Research Lead

    New Zealand

  • Charlotte Gilbert

    Fundraising Lead

    USA

  • Sue Weng

    Data Collection & Analysis

    USA

  • John Delaney

    Marketing and Website

    Australia

Cure ML Professional Advisory Board

  • Alessandra d'Azzo

    St. Jude Children's Research Hospital, USA

  • Ming Li

    University of Michigan, USA

  • A/Prof Enrico Moro

    University of Padova, Italy

  • Stephan Tiede

    University Medical Center Hamburg - Eppendorf

  • Julia Taravella

    Founder of the Rare Trait Hope Fund